Search    
MSDS
: 
Progesterone
CAS
: 
57-83-0
SYNONYM : 

   * Agolutin
   * Bio-luton
   * Corlutin
   * Corlutina
   * Corluvite
   * Corporin
   * Corpus luteum hormone
   * delta(sup 4)-Pregnene-3,20-dione
   * Flavolutan
   * Fologenon
   * Gesterol 100
   * Gestone
   * Gestormone
   * Glanducorpin
   * Gynlutin
   * Gynoluton
   * Hormoflaveine
   * Hormoluton
   * Lingusorbs
   * Lipo-lutin
   * Lucorteum Sol
   * Luteal hormone
   * Luteinique
   * Luteodyn
   * Luteogan
   * Luteohormone
   * Luteol
   * Luteosan
   * Luteostab
   * Luteovis
   * Lutex
   * Lutidon
   * Lutocyclin
   * Lutocyclin M
   * Lutocylin
   * Lutoform
   * Lutogyl
   * Lutren
   * Lutromone
   * Nalutron
   * NSC-9704
   * Percutacrine Luteinique
   * Piaponon
   * Pregn-4-ene-3,20-dione
   * 4-Pregnene-3,20-dione
   * Primolut
   * Progekan
   * Progestasert
   * Progesterol
   * beta-Progesterone
   * Progesteronum
   * Progestin
   * Progestone
   * Prolidon
   * Prolutone
   * Syngesterone
   * Syngestrets
   * Synovex S
   * Syntolutan.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione
17.alpha.-Progesterone
3,20-Pregnene-4
57-83-0
6.alpha.-Methylpregn-4-en-17.alpha.-ol-3,20-dione
Colprosterone
Cyclogest
Gestron
Gynolutone
Lipo-Lutin
Luteine
Luteocrin normale
Luteopur
Lutociclina
Lutocylol
MPA
Membrettes
Methylpregnone
NSC9704
Pranone
Pregn-4-ene-3,20-dione, 17.alpha.-hydroxy-6.alpha.-methyl-
Pregnenedione
Progestosol
Progestron
Progestronol
Prolets
Prolutin
Protormone
Utrogestan
WLN: L E5 B666 OV MUTJ A1 E1 FV1
component of Cyclogesterin
NSC64377
AIDS-070516
AIDS070516
Lipolutin
17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione
17alpha-Progesterone
6alpha-Methylpregn-4-en-17alpha-ol-3,20-dione
AI3-51682
CCRIS 533
CMC_13406
Crinone
Crinone progesterone gel
D4-Pregnene-3,20-dione
Gesterol 50
Gestiron
HSDB 3389
Lugesteron
Luteal Hormone
Luteol (VAN)
Luteum
Lutocuclin M
Pregn-4-ene-3,20-dione, 17alpha-hydroxy-6alpha-methyl-
Prochieve
Progeffik
Progestogel
Progestol
Projestaject
Prometrium
Prontogest
U 3672
Vitarrine
delta(sup4)-Pregnene-3,20-dione
Crinone (TN)
D00066
Progesterone (JP15/USP/INN)
Prometrium (TN)
Prestwick_411
NCGC00090798-01
NCGC00090798-02
PREGANE-3,20-DIONE
D011374
Progesterone, (13 alpha,17 alpha)-(+-)-Isomer
Progesterone, (17 alpha)-Isomer
Progesterone, (9 beta,10 alpha)-Isomer
Delta4 -Pregnen-3,20-dione
PROGESTERONE
MOLECULAR FORMULA: C21-H30-O2
MOLECULAR WEIGHT: 314.51
MELTING POINT: 128-132 ºC
WATER SOLUBILITY: %RP_SMALLER%0.1 g/100 mL at 19 ºC
TYPE OF TEST: LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE: Intraperitoneal SPECIES OBSERVED: Rodent - rat DOSE / DURATION: 327 mg/kg TOXIC EFFECTS: Details of toxic effects not reported other than lethal dose value REFERENCE: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,1183,1995 TYPE OF TEST: LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE: Intraperitoneal SPECIES OBSERVED: Rodent - rat DOSE / DURATION: 327 mg/kg TOXIC EFFECTS: Details of toxic effects not reported other than lethal dose value REFERENCE: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,1183,1995 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Subcutaneous SPECIES OBSERVED: Rodent - mouse DOSE DURATION: 40 mg/kg TOXIC EFFECTS: Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors REFERENCE: BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 19,824,1965 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: TDLo - Lowest published toxic dose ROUTE OF EXPOSURE: Oral SPECIES OBSERVED: Human - woman DOSE: 200 mg/kg SEX DURATION: female 20 day(s) pre-mating TOXIC EFFECTS: Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE: AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 85,427,1963 TYPE OF TEST: DNA inhibition TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition ROUTE OF EXPOSURE: Oral TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition ROUTE OF EXPOSURE: Oral TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition ROUTE OF EXPOSURE: Oral TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition ROUTE OF EXPOSURE: Oral TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition ROUTE OF EXPOSURE: Oral TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 TYPE OF TEST: DNA inhibition ROUTE OF EXPOSURE: Oral TEST SYSTEM: Human Lymphocyte DOSE DURATION: 5 umol/L REFERENCE: PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 146,401,1974 REFERENCE: IARC Cancer Review:Animal Sufficient Evidence IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,296,1987 TOXICOLOGY REVIEW ACEDAB Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- Volume(issue)/page/year: 185,169,1974 TOXICOLOGY REVIEW PCNAA8 Pediatric Clinics of North America. (W.B. Saunders Co., W. Washington Sq., Philadelphia, PA 19105) V.1- 1954- Volume(issue)/page/year: 8,413,1961 TOXICOLOGY REVIEW JOPDAB Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- Volume(issue)/page/year: 59,1,1961 TOXICOLOGY REVIEW CMROCX Current Medical Research and Opinion. (Clayton-Wray Pub. Ltd., 1a High St., Alton, Hants., UK) V.1- 1972- Volume(issue)/page/year: 4,309,1976 TOXICOLOGY REVIEW ACEDAB Acta Endocrinologica, Supplementum (Copenhagen). (Periodica, Skolegade 12 E, DK-2500 Valby, Denmark) No.1- 1948- Volume(issue)/page/year: 51,671,1960 TOXICOLOGY REVIEW JRPMAP Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- Volume(issue)/page/year: 13,113,1974 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA: NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84510 No. of Facilities: 134 (estimated) No. of Industries: 2 No. of Occupations: 9 No. of Employees: 22963 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84510 No. of Facilities: 55 (estimated) No. of Industries: 2 No. of Occupations: 2 No. of Employees: 287 (estimated) No. of Female Employees: 55 (estimated) NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA: EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat EPA GENETOX PROGRAM 1988, Positive: Cell transform.-RLV F344 rat embryo EPA GENETOX PROGRAM 1988, Positive: Sperm morphology-human EPA GENETOX PROGRAM 1988, Negative: Cell transform.-BALB/c-3T3; SHE-clonal assay EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9 EPA TSCA Section 8(b) CHEMICAL INVENTORY NTP 9th Report on Carcinogens,2000:Reasonably anticipated to be human carcinogen
Search More   
CHEMICAL GROUP
NAMECASSYSNONYMS
Prevocel #1281296-82-4
Prevotsel NG-12
Prevotsel wofp-100-NF
Primary aliphatic (C10-C16) amines
Primary fatty (C10-C13) alcohols
Primene JM-T68955-54-4
* Amines, C16-22-tert-alkyl68955-54-4
EINECS 273-280-7
Primene JM-T
t-Alkyl(C16-C22) primary amines
PP 554
* Czech experimental compound PP 554
Primene 81-R68955-53-3
* Amines, C12-14-tert-alkyl68955-53-3
EINECS 273-279-1
Primene 81-R
t-Alkyl (C12-C14) primary amines
Primex8041-44-98041-44-9
Primex
Primula denticulata Sm., extract
* Bishkopra, extract
Primula floribunda Wall., extract
Primula petiolaris Wall., extract
Primulic acid53078-36-7
* Primulasaure4-18-00-05150 (Beilstein Handbook Reference)
53078-36-7
BRN 0078553
NSC 409073
Primulasaure [German]
Primulic acid
beta-D-Galactopyranosiduronic acid, (3beta,16alpha)-16,28-dihydroxyolean-12-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(O-beta-D-glucopyranosyl-(1-6)-beta-D-galactopyranosyl-(1- 4))- (9CI)
.beta.-D-Galactopyranosiduronic acid, (3.beta.,16.alpha.)-16,28-dihydroxyolean-12-en-3-yl O-6-deoxy-.alpha.-L-mannopyranosyl-(1.fwdarw.2)-O-[O-.beta.-D-glucopyranosyl-(1.fwdarw.6)-.beta.-D-galactopyranosyl-(1.fwdarw.4)]-
NSC409073
PRIMULIC ACID
Primuline, sodium salt8064-60-6
* C.I. Direct Yellow 7, sodium salt
* Thioflavine S8064-60-6
C.I. 49000
C.I. Direct Yellow 59
NSC72275
Primuline
Primuline, sodium salt
Primulinesulfonic acid
[2,6':2',6''-Terbenzothiazole]-7-sulfonic acid, 2''-(4-aminophenyl)-6-methyl-, monosodium salt, mixt. with 2'-(4-aminophenyl)-6-methyl[2,6'-bibenzothiazole]-7-sulfonic acid monosodium salt
(2,6'-:2',6''-Terbenzothiazole)-7-sulfonic acid, 2''-(4-aminophenyl)-6-methyl-, monosodium salt, mixture with 2'-(4-aminophenyl)-6-methyl(2,6'-benzothiazole)-7-sulfonic acid, monosodium salt
(2,6':2',6''-Terbenzothiazole)-7-sulfonic acid, 2''-(4-aminophenyl)-6-methyl-, monosodium salt, mixt. with 2'-(4-aminophenyl)-6-methyl(2,6-bibenzothiazole)-7-sulfonic acid monosodium salt
NSC 72275
PRIMULIN
PRIMULINE
Primycin, sulfate30003-49-7
* Debrycin sulfate
* Ebrimycin
* Primycin A(sub 1) sulfate
Primycin A(sub 1),
1,35-deepoxy-37-deoxy-1,37-epoxy-35-hydroxy-,
monoacetate (salt)		128644-53-1
* 1,35-Deepoxy-37-deoxy-1,37-epoxy-35-hydroxyprimycin A(sub 1) monoacetate
(salt)
* Pseudo-primycin A(sub 1) acetate1,35-Deepoxy-37-deoxy-1,37-epoxy-35-hydroxyprimycin A(sub 1) monoacetate (salt)
128644-53-1
Primycin A(sub 1), 1,35-deepoxy-37-deoxy-1,37-epoxy-35-hydroxy-, monoacetate (salt)
Prinsepia utilis Royle, extract
Practomycin C52810-78-352810-78-3
Practomycin C
Printing processes
Priva cordifolia (L.f.) Druce, extract
* Priva leptostachya Juss., extract
Proactinomycin A1404-33-71404-33-7
Proactinomycin A
Proactinomycin B1404-34-81404-34-8
Proactinomycin B
Proactinomycin C1404-35-91404-35-9
Proactinomycin C
Proceomycin11006-50-111006-50-1
Proceomycin
Proceroside25323-74-4
* Proceroside (Calotropis)25323-74-4
Prodeco prodesolv 128 D
Prodigiozan9057-00-5
* Prodigiosan9057-00-5
Prodigiozan
Proflamin96231-73-196231-73-1
Proflamin
Pramitol 5PS
Progesterone57-83-0
* Agolutin
* Bio-luton
* Corlutin
* Corlutina
* Corluvite
* Corporin
* Corpus luteum hormone
* delta(sup 4)-Pregnene-3,20-dione
* Flavolutan
* Fologenon
* Gesterol 100
* Gestone
* Gestormone
* Glanducorpin
* Gynlutin
* Gynoluton
* Hormoflaveine
* Hormoluton
* Lingusorbs
* Lipo-lutin
* Lucorteum Sol
* Luteal hormone
* Luteinique
* Luteodyn
* Luteogan
* Luteohormone
* Luteol
* Luteosan
* Luteostab
* Luteovis
* Lutex
* Lutidon
* Lutocyclin
* Lutocyclin M
* Lutocylin
* Lutoform
* Lutogyl
* Lutren
* Lutromone
* Nalutron
* NSC-9704
* Percutacrine Luteinique
* Piaponon
* Pregn-4-ene-3,20-dione
* 4-Pregnene-3,20-dione
* Primolut
* Progekan
* Progestasert
* Progesterol
* beta-Progesterone
* Progesteronum
* Progestin
* Progestone
* Prolidon
* Prolutone
* Syngesterone
* Syngestrets
* Synovex S
* Syntolutan.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione
17.alpha.-Progesterone
3,20-Pregnene-4
57-83-0
6.alpha.-Methylpregn-4-en-17.alpha.-ol-3,20-dione
Colprosterone
Cyclogest
Gestron
Gynolutone
Lipo-Lutin
Luteine
Luteocrin normale
Luteopur
Lutociclina
Lutocylol
MPA
Membrettes
Methylpregnone
NSC9704
Pranone
Pregn-4-ene-3,20-dione, 17.alpha.-hydroxy-6.alpha.-methyl-
Pregnenedione
Progestosol
Progestron
Progestronol
Prolets
Prolutin
Protormone
Utrogestan
WLN: L E5 B666 OV MUTJ A1 E1 FV1
component of Cyclogesterin
NSC64377
AIDS-070516
AIDS070516
Lipolutin
17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione
17alpha-Progesterone
6alpha-Methylpregn-4-en-17alpha-ol-3,20-dione
AI3-51682
CCRIS 533
CMC_13406
Crinone
Crinone progesterone gel
D4-Pregnene-3,20-dione
Gesterol 50
Gestiron
HSDB 3389
Lugesteron
Luteal Hormone
Luteol (VAN)
Luteum
Lutocuclin M
Pregn-4-ene-3,20-dione, 17alpha-hydroxy-6alpha-methyl-
Prochieve
Progeffik
Progestogel
Progestol
Projestaject
Prometrium
Prontogest
U 3672
Vitarrine
delta(sup4)-Pregnene-3,20-dione
Crinone (TN)
D00066
Progesterone (JP15/USP/INN)
Prometrium (TN)
Prestwick_411
NCGC00090798-01
NCGC00090798-02
PREGANE-3,20-DIONE
D011374
Progesterone, (13 alpha,17 alpha)-(+-)-Isomer
Progesterone, (17 alpha)-Isomer
Progesterone, (9 beta,10 alpha)-Isomer
Delta4 -Pregnen-3,20-dione
PROGESTERONE
Progesterone, dihydroxy-, acetophenide mixed with
estradiol enanthate (15:1)
* DPA and estradiol enanthate (15:1)
Prolactin9002-62-4
* Adenohypophyseal luteotropin
* Anterior pituitary luteotropin
* Bovine lactogenic hormone
* Bovine prolactin
* Galctin
* Lactogen
* Lactogenic hormone
* Lactosomatotropic hormone
* Luteotrophin
* Luteotropic hormone
* Luteotropic Hormone LTH
* Luteotropin
* Mammotropin
* Ovine prolactin
* Paralctin
* Pituitary lactogenic hormone9002-62-4
Galactin
Lactogen, pituitary
Lactogenic hormone, pituitary
Lactogenic pituitary hormones
Luteotropic hormone LTH
NSC25935
Panlitar
Paralactin
Pituitary gland, lactogenic hormone
Pituitary hormones, lactogenic
Prolactin (8CI 9CI)
CCRIS 704
Gonadotropin, prolactin
Gonadotropin,luteotropic hormone
Lactin
Lactogenic hormone (VAN)
Lactosomatotropic hormone (VAN)
Lactosomatotropin
NSC 25935
Prolactin, human
L-Prolinamide,
N-((1-(2-aminoethyl)hexahydro-2,6-dioxo-4-pyrimidinyl
)carbonyl)-L-histidyl -, (RS)-, dihydrate
L-Prolinamide,
N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-N-methy
l-D-phenylalanyl-, (S)-, sulfate (1:1)		126721-07-1105806-65-3 (Parent)
126721-07-1
L-Prolinamide, N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-N-methyl-D-phenylalanyl-, (S)-, sulfate (1:1)
L-Prolinamide, N-methyl-D-phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (S)-, sulfate (1:1)
UNII-VB4VCH77JV
D03722
Efegatran sulfate
Efegatran sulfate (USAN)
L-Prolinamide,
N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-D-pheny
lalanyl-, sulfate, (S)-		83997-16-4
* GYKI 14166
* (S)-D-Phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-L-proli
namide sulfate (1:1)
* D-Phenylalanyl-L-prolyl-L-arginine aldehyde sulfate (1:1)
* RGH-2958(S)-D-Phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-L-prolinamide sulfate (1:1)
83997-16-4
L-Prolinamide, N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-D-phenylalanyl-, sulfate, (S)-
L-Prolinamide,
N-(4-((aminoiminomethyl)amino)-1-cyanobutyl)-D-phenyl
alanyl-, (S)-		111009-86-0
* (S)-N-(4-((Aminoiminomethyl)amino)-1-cyanobutyl)-D-phenylalanyl-L-prolin
amide
* D-Phenylalanyl-L-prolyl-L-arginine nitrile(S)-N-(4-((Aminoiminomethyl)amino)-1-cyanobutyl)-D-phenylalanyl-L-prolinamide
111009-86-0
L-Prolinamide, D-phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-cyanobutyl)-, (S)-
L-Prolinamide, N-(4-((aminoiminomethyl)amino)-1-cyanobutyl)-D-phenylalanyl-, (S)-
Phenylalanyl-prolyl-arginine nitrile
L-Prolinamide,
N-((1-(carboxymethyl)hexahydro-2,6-dioxo-4-pyrimidiny
l)carbonyl)-L-histidy l-, (S)-, hydrate (2:3)		128056-14-4128056-14-4
L-Prolinamide, N-((1-(carboxymethyl)hexahydro-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate (2:3)
L-Prolinamide,
N-((2-(10,11,17,18,23,24,25,26,27,28-decahydro-14-met
hyl-11-(2-(methylamin
o)-2-oxoethyl)-18,28-bis(1-methylethyl)-9,16,23,26-te
traoxo-9H,16H-8,5:15, 12:22,19:32,29:36,33-
pentanitrilo-5H,29H,33H-pyrido(3,2-a1)(1,11,18,25,31,
4,7,14,21)pentathiate traazacyclotetratri
acontin-2-yl)-4-thiazolyl)carbonyl)-L-seryl-		156620-48-3
* Amythiamicin B156620-48-3
L-Prolinamide, N-((2-(10,11,17,18,23,24,25,26,27,28-decahydro-14-methyl-11-(2-(methylamino)-2-oxoethyl)-18,28-bis(1-methylethyl)-9,16,23,26-tetraoxo-9H,16H-8,5:15,12:22,19:32,29:36,33-pentanitrilo-5H,29H,33H-pyrido(3,2-a1)(1,11,18,25,31,4,7,14,21)pentathiatetraazacyclotetratriacontin-2-yl)-4-thiazolyl)carbonyl)-L-seryl-
L-Prolinamide,
N-((1,1-dimethylethoxy)carbonyl)-D-phenylalanyl-N-(4-
((aminoiminomethyl) amino)-1-formylbutyl)-, (S)-,
sulfate (2:1)		83861-29-4
* GYKI-1445183861-29-4
L-Prolinamide, N-((1,1-dimethylethoxy)carbonyl)-D-phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (S)-, sulfate (2:1)
Praseodymium chloride10361-79-210361-79-2
NSC84276
Praseodymium chloride
Praseodymium chloride (PrCl3)
Praseodymium chloride, PrCl3
Praseodymium trichloride
Praseodymium(III) chloride
WLN: PR G3
EINECS 233-794-4
NSC 84276
L-Prolinamide,
N,N-dimethyl-L-phenylalanyl-N-(5,8-dioxo-3-phenyl-7-(
phenylmethyl)-2-oxa-6 ,9-
diazabicyclo(10.2.2)hexadeca-10,12,14,15-tetraen-4-yl
)-, (3R-(3R*,4S*,7S*))-, sulfamate		19542-40-6
* Adouetine Z amidosulfonate19542-40-6
Adouetine Z amidosulfonate [French]
L-Prolinamide, N,N-dimethyl-L-phenylalanyl-N-(5,8-dioxo-3-phenyl-7-(phenylmethyl)-2-oxa-6,9-diazabicyclo(10.2.2)hexadeca-10,12,14,15-tetraen-4-yl)-, (3R-(3R*,4S*,7S*))-, sulfamate
L-Prolinamide,
N-((1-(2-fluoroethyl)hexahydro-2,6-dioxo-4-pyrimidiny
l)carbonyl)-L-histidy l-, (S)-, hydrate		128056-05-3128056-05-3
L-Prolinamide, N-((1-(2-fluoroethyl)hexahydro-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate
L-Prolinamide,
N-((hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbony
l)-L-histidyl-, hydrate		128056-06-4
* N-((Hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-L-pro
linamide hydrate128056-06-4
L-Prolinamide, N-((hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, hydrate
N-((Hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-L-prolinamide hydrate
L-Prolinamide,
N-((hexahydro-1-butyl-3-methyl-2,6-dioxo-4-pyrimidiny
l)carbonyl)-L-histidy l-, (RS)-, hydrate
L-Prolinamide,
N-((hexahydro-1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)ca
rbonyl)-L-histidyl-, (S)-, hemihydrate		128056-17-7128056-17-7
L-Prolinamide, N-((hexahydro-1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hemihydrate
L-Prolinamide,
N-((hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbon
yl)-L-histidyl-, hydrate		128083-59-0
* N-((Hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbonyl)-L-histidyl-L-pr
olinamide hydrate128083-59-0
L-Prolinamide, N-((hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbonyl)-L-histidyl-, hydrate
N-((Hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbonyl)-L-histidyl-L-prolinamide hydrate
L-Prolinamide,
N-((hexahydro-2,6-dioxo-1-(2-(phenylmethoxy)ethyl)-4-
pyrimidinyl)carbonyl) -L- histidyl-, (RS)-
L-Prolinamide,
N-((hexahydro-2,6-dioxo-1-(phenylmethyl)-4-pyrimidiny
l)carbonyl)-L-histidy l-, hydrate		128056-07-5128056-07-5
L-Prolinamide, N-((hexahydro-2,6-dioxo-1-(phenylmethyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, hydrate
L-Prolinamide,
N-((hexahydro-2,6-dioxo-3-(phenylmethyl)-4-pyrimidiny
l)carbonyl)-L-histidy l-, (S)-, hydrate		128056-16-6128056-16-6
L-Prolinamide, N-((hexahydro-2,6-dioxo-3-(phenylmethyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate
L-Prolinamide,
N-((hexahydro-2,6-dioxo-1-(2-propenyl)-4-pyrimidinyl)
carbonyl)-L-histidyl-, (S)-, hydrate		128083-58-9128083-58-9
L-Prolinamide, N-((hexahydro-2,6-dioxo-1-(2-propenyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net